Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00500123 · ClinicalTrials.gov registry record

The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study

A clinical trial of Alpha-1 Antitrypsin Deficiency, sponsored by University of Florida.

Recruiting
Registry status
50,000
Enrollment target
1
Study location

NCT00500123 is a study of Alpha-1 Antitrypsin Deficiency that is actively recruiting participants, run by University of Florida. The registered enrollment target is 50,000 participants, above the 300-participant average among 18 other Alpha-1 Antitrypsin Deficiency trials with a reported enrollment target (16567% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00500123, a study of Alpha-1 Antitrypsin Deficiency, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
50,000 participants
Enrollment target
1
Study location

Study Summary

The Alpha-1 Coded Testing (ACT) Study was established to study genetic testing and outcomes of individuals at risk for alpha-1 antitrypsin deficiency.

Conditions Studied

Alpha-1 Antitrypsin Deficiency

Interventions

  • PROCEDURE Alpha-1 Antitrypsin Genotype

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 50,000 participants
Start Date 2001-01
Est. Completion 2050-01

Sponsor

University of Florida

1,106 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00500123

The ClinicalTrials.gov registry entry for NCT00500123 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 300-participant average among 18 other Alpha-1 Antitrypsin Deficiency trials with a reported enrollment target (16567% higher). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alpha-1 Antitrypsin Deficiency appearing as the primary indexed condition, and to 1 intervention - of which Alpha-1 Antitrypsin Genotype is the first listed.

NCT00500123 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT00500123 about?

NCT00500123 is a clinical study titled "The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study". The Alpha-1 Coded Testing (ACT) Study was established to study genetic testing and outcomes of individuals at risk for alpha-1 antitrypsin deficiency.

What is the current status of trial NCT00500123?

This trial is currently recruiting. The enrollment target is 50,000 participants. The study started on 2001-01. Estimated completion is 2050-01.

What conditions does trial NCT00500123 study?

This clinical trial studies the following conditions: Alpha-1 Antitrypsin Deficiency.

What interventions are being tested in trial NCT00500123?

The interventions under investigation include: Alpha-1 Antitrypsin Genotype (PROCEDURE).

Who is sponsoring clinical trial NCT00500123?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00500123 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alpha-1 Antitrypsin Deficiency

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alpha-1 Antitrypsin Deficiency

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.